Search

Objectives. A critical question in the activity engagement literature is whether physical exercise alters the trajectory of age-related cognitive decline (differential preservation) or is associated with enhanced baseline cognitive ability (preserved differentiation). Further, investigations considering that these relations may differ across young, middle, and older adulthood are rare. Method. We evaluated data from the PATH Through Life Project, where participants aged 20–24, 40–44, and 60–64 years at baseline (n = 6,869) completed physical activity (PA; mild, moderate, and vigorous) and cognitive measurements thrice over 8 years. Results. Multilevel models accounting for employment status, sex, education, health, and mental and social activity showed that between-person differences in PA participation positively predicted baseline performance on fluid cognitive ability (perceptual speed, short-term memory, working memory, and episodic memory). These effects were similar across age groups, but strongest for the youngest cohort, for whom there was also evidence of covariation between within-person change in PA and cognitive score. PA was not associated with change in cognition over time. Discussion. Results support preserved differentiation, where physically active adults have higher initial cognitive ability, and the advantage is maintained over time. PA appears to be unique in showing differences across young, middle, and older adulthood in predicting cognition. [ABSTRACT FROM PUBLISHER]

We aimed to characterize the nature and magnitude of cognitive decline in a group of adults with amnestic mild cognitive impairment (aMCI) with high and low levels of amyloid-β (Aβ) in relation to healthy older adults with low Aβ levels. Healthy older adults and adults with aMCI enrolled in the Australian Imaging, Biomarker, and Lifestyle study, completed the CogState brief battery at baseline and 18 months, and underwent positron emission tomography neuroimaging for Aβ at baseline. In this study, we included adults with MCI who had been classified as having high and low levels of Aβ and healthy older adults who had been classified as having low levels of Aβ. Linear model analyses adjusted for baseline cognitive function indicated that relative to healthy older adults with low Aβ, adults with aMCI and high Aβ showed greater decline in working memory and in verbal and visual episodic memory at 18 months. Adults with aMCI and low Aβ also showed greater decline in working memory; however they did not evidence any decline in episodic memory at 18 months. The results of our study suggests that relative to healthy older adults and adults with aMCI with low Aβ, adults with aMCI and high levels of Aβ showed faster rates of decline on measures of episodic memory over 18 months, and this was approximately twice that observed previously for healthy older adults with high Aβ levels. [ABSTRACT FROM AUTHOR]